The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects
Clinical trial NCT05977101 · UNKNOWN
Trial details
- NCT number
- NCT05977101
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-17
- Primary completion
- 2023-12-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.